Stobart Group Ltd (LON:STOB) said it was confident about the outlook for the new year as it ramps up investment in expanding its London Southend Airport after de-risking the balance sheet through disposals.
IQ-AI Limited (LON:IQAI) said its chairman, Trevor Brown has subscribed for £250,000 in nominal amount of 6% unsecured convertible loan notes 2025 (CLNs), convertible into 16,666,666 ordinary shares at a price of 1.5p each. The group said funds raised as a result of the issue of the CLNs will be used to provide additional working capital for product development. It noted that Brown is directly and indirectly (through Free Association Books, a company in which he is interested) interested in 36,083,025 ordinary shares in the company, equivalent to 29.98% of the issued ordinary share capital.
Alba Mineral Resources plc (LON:ALBA) has revealed details of the latest batch of results from the Clogau gold project in Wales. Results from 243 samples, among 1,200 samples taken in a recent programme, include gold-in-sample grades from two new anomaly areas which are located away from and separate to the historic mining area.
INTOSOL Holdings PLC (LON:INTO) shares had some shine to them on Wednesday after the travel firm agreed a final purchase contract for its flagship luxury hotel, Oceans Wilderness. The group said it will pay around €1.97mln for the nine-bedroom boutique hotel, which is located in the scenic Garden Route area of South Africa.
Bluejay Mining PLC (LON:JAY) has revealed an upgrade to the resources at the Dundas ilmenite project, in Greenland. The project’s total mineral resource increases by 15% to 117mln tonnes, at 6.1% ilmenite in-situ. Big Pic in January.
Aquaculture and genetics group Benchmark Holdings PLC (LON:BMK) is to take full control of its Chile-based salmon breeding joint venture. Partner AquaChile was acquired by Agrosuper in January and talks have now started over the dissolution of the JV.
Strategic Minerals PLC (LON:SML) has signed a Deed of Variation with New Age Exploration Limited (NAE) to defer the initial payment date for the acquisition of NAE's 50% shareholding in Cornwall Resources Limited (CRL) from 30 May 2019 to 27 June 2019. The AIM-listed producing mineral company said the deferral is to allow for the expected receipt of the funds from Cobre's major client.
Premier African Minerals PLC (LON:PREM) has started talks with other parties about the development of the RHA tungsten mine. The junior has agreed to a direct approach from a potential alternative buyer of wolframite, while two Development Finance Institutions are to conduct due diligence.
ValiRx Plc (LON:VAL) said the dose ranging study of its lead drug continued as it outlined potential next steps. In an update alongside its full-year results, ValiRx also said it would either out-licence VAL201 to a major pharmaceutical company or proceed to a phase llb study once dose-ranging is complete. Big Pic in May.
Afarak Group PLC (LON:AFRK) has told investors it will issue new equity as part of transactions to increase its ownership stake in a number of South African mining assets. In total, the company will be issuing 2.12mln new shares. They can be issued within existing shareholder authorisations and the agreements are not expected to have any major impact on Afarak or its business.
Avation PLC (LON:AVAP) has revealed that Crédit Agricole Corporate and Investment Bank acted as sole arranger, facility agent and security trustee for the commercial financing of the new ATR 72-600 turboprop aircraft the firm delivered to Cebu Air, Inc. at the manufacturer's facility in Toulouse, France, as announced on May 24. Avation's executive chairman, Jeff Chatfield said: "We were pleased to enjoy commercial finance for our 46th aircraft."
W Resources PLC (LON:WRES), the tungsten, tin and gold mining company with assets in Spain and Portugal, is has announced the appointment of Alternative Resource Capital/Shard Capital as its joint broker alongside Turner Pope Investments with immediate effect.
MaxCyte (LON:MXCT) (LON:MXCS), the global cell-based medicines and life sciences company, said it will host a Capital Markets Day for analysts and institutional investors on Thursday 11 July, from 15.00-17.30 BST in London. The group said discussion topics will include MaxCyte's partner programmes and in-house oncology pipeline, and trends in the cell therapy industry, and demonstrations will also be given of the company's new products.